BiotechTube
Home/Tolremo Therapeutics/Alessandra Cesano, MD, PhD
AC

Alessandra Cesano, MD, PhD

Chief Medical Officer

Tolremo Therapeutics

Therapeutic Areas

Oncology

Tolremo Therapeutics Pipeline

DrugIndicationPhase
TT125-802Solid tumors and hematological malignancies (for prevention of resistance)Phase 1

Leadership Team at Tolremo Therapeutics

SF
Stefanie Flückiger-Mangual, PhD
CEO
JC
Jessica Corson
Chief Business Officer
CE
Claudia Escher, PhD
COO
JM
Julie M. Cherrington, PhD
Chair of the Board
View full Tolremo Therapeutics profile